Key points are not available for this paper at this time.
Coagulopathy is a major cause of morbidity and mortality in COVID-19 patients. Hypercoagulability in COVID-19 results in deep vein thrombosis, thromboembolic complications, and diffuse intravascular coagulation. Microbiome dysbiosis influences the clinical course of COVID-19. However, the role of dysbiosis in COVID-19-associated coagulopathy is not fully understood.
Building similarity graph...
Analyzing shared references across papers
Loading...
Tatsuki Tsuruga
Hajime Fujimoto
Taro Yasuma
Journal of Thrombosis and Haemostasis
University of Illinois Urbana-Champaign
Mie University
Tosei General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Tsuruga et al. (Tue,) studied this question.
www.synapsesocial.com/papers/68e75a06b6db6435876d1041 — DOI: https://doi.org/10.1016/j.jtha.2024.02.014